Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julian H Slade

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Pharmacotherapy|October 30, 2007
Antidepressant agents for the treatment of chronic pain and depressionMichael W Jann, Julian H Slade
Clinical Colorectal Cancer|August 23, 2011
Fatal diffuse alveolar damage associated with oxaliplatin administrationJack Watkins, Julian H Slade, Alex Phan, et al.
Gastrointestinal Cancer Research : GCR|February 2, 2012
Chemotherapy outcomes for the treatment of unresectable intrahepatic and hilar cholangiocarcinoma: a retrospective analysisKaren R Eckmann, Dina K Patel, Andrea Landgraf, et al.
Clinical Colorectal Cancer|October 14, 2009
Portal hypertension associated with oxaliplatin administration: clinical manifestations of hepatic sinusoidal injuryJulian H Slade, Mona L Alattar, David R Fogelman, et al.
Cancer Research Communications|August 27, 2025
Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase 1 UnitCamila Braganca Xavier, Clark R Andersen, JoAnn Lim, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Pharmacotherapy|October 30, 2007
Antidepressant agents for the treatment of chronic pain and depressionMichael W Jann, Julian H Slade
Clinical Colorectal Cancer|August 23, 2011
Fatal diffuse alveolar damage associated with oxaliplatin administrationJack Watkins, Julian H Slade, Alex Phan, et al.
Gastrointestinal Cancer Research : GCR|February 2, 2012
Chemotherapy outcomes for the treatment of unresectable intrahepatic and hilar cholangiocarcinoma: a retrospective analysisKaren R Eckmann, Dina K Patel, Andrea Landgraf, et al.
Clinical Colorectal Cancer|October 14, 2009
Portal hypertension associated with oxaliplatin administration: clinical manifestations of hepatic sinusoidal injuryJulian H Slade, Mona L Alattar, David R Fogelman, et al.
Cancer Research Communications|August 27, 2025
Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase 1 UnitCamila Braganca Xavier, Clark R Andersen, JoAnn Lim, et al.
Pageof 1